Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
764.440.02%
QQQ
715.040.02%
BTC/USD
77583.941.021%
DIA
525.910.02%
GLD
398.290.12%
TLT
80.930.07%

Adagene Inc

ADAGNASDAQ
Trade with Public
Trade with Public
$3.40
0.092.72%
At close: Sep 11, 5:00 PM EST
$3.15
-0.25-7.35%
After Hours: Sep 11, 8:46 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Adagene Analyst Price Targets

Wall Street analyst price targets and consensus rating for Adagene (ADAG).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

5Buy
Consensus RatingBuy# Analysts5Avg. Consensus PT$8Upside to Avg. PT+166.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 10, 2026Chardan CapitalGautam ChukkaInitiateBuy$9
Apr 6, 2026GuggenheimPaul JengPT RaiseBuy$9→$10
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Chardan Capital Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

Chardan Capital analyst Gautam Chukka initiates coverage on Adagene (NASDAQ:ADAG) with a Buy rating and announces Price Target of $9.
Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Adagene, Raises Price Target to $10

Guggenheim analyst Paul Jeng maintains Adagene (NASDAQ:ADAG) with a Buy and raises the price target from $9 to $10.
Benzinga Newsdesk

PRO
Guggenheim Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

Guggenheim analyst Paul Jeng initiates coverage on Adagene (NASDAQ:ADAG) with a Buy rating and announces Price Target of $9.
Benzinga Newsdesk

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

LUCID CAPITAL MARKETS analyst Christopher Liu initiates coverage on Adagene (NASDAQ:ADAG) with a Buy rating and announces Price Target of $9.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Adagene, Lowers Price Target to $7

HC Wainwright & Co. analyst Arthur He maintains Adagene (NASDAQ:ADAG) with a Buy and lowers the price target from $8 to $7.
Benzinga Newsdesk

This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved